Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension

dc.contributor.authorSahin, Abdurrahman
dc.contributor.authorArtas, Hakan
dc.contributor.authorTunc, Nurettin
dc.contributor.authorYalniz, Mehmet
dc.contributor.authorBahcecioglu, Ibrahim Halil
dc.date.accessioned2026-08-12T18:06:54Z
dc.date.issued2018
dc.departmentFırat Üniversitesi
dc.description.abstractPortal hypertension (PHT) leads to several alterations on hematological indices (HI). The aim of the study is to investigate the differences in HI between cirrhotic subjects and subjects who have noncirrhotic PHT (NCPHT). This retrospective study included 328 patients with PHT (239 cirrhosis and 89 NCPHT). Demographic and clinical features, endoscopic and radiological findings, and HI including neutrophil to lymphocyte ratio (NLR) at the time of PHT diagnosis were recorded. Severity of cirrhosis was assessed according to the Child-Turcotte-Pugh (CTP) classification and Model for End-Stage Liver Disease (MELD) scores. Hematological abnormalities were found in 92.5% of cirrhotic patients and in 55.1% of patients with NCPHT (p < 0.001). While thrombocytopenia was the most common HI in patients with cirrhosis, anemia was the most prevalent HI in NCPHT group. In the cirrhotic group, the NLR was the only parameter to differentiate each CTP group from two others. The NLR value increased with the severity of cirrhosis (2.28 +/- 0.14 in CTP-A, 2.85 +/- 0.19 in CTP-B and 3.26 +/- 0.37 in CTP-C). The AUROC of NLR was 0.692 for differentiating compensated cirrhotic patients from decompensated. Hematological abnormalities are more prevalent and more severe in cirrhotic patients compared to patients with NCPHT. NLR may be used to assess the severity of cirrhosis.
dc.identifier.doi10.3390/jcm7080196
dc.identifier.issn2077-0383
dc.identifier.issue8
dc.identifier.orcid0000-0003-4462-5953
dc.identifier.orcid0000-0001-5477-9492
dc.identifier.orcid0000-0001-7776-4154
dc.identifier.pmid30072589
dc.identifier.scopus2-s2.0-85108525178
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.3390/jcm7080196
dc.identifier.urihttps://hdl.handle.net/11508/62497
dc.identifier.volume7
dc.identifier.wosWOS:000442602700016
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMdpi
dc.relation.ispartofJournal of Clinical Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjecthematological indices
dc.subjectportal hypertension
dc.subjectcirrhosis
dc.subjectnoncirrhotic portal hypertension
dc.subjectneutrophil to lymphocyte ratio
dc.titleHematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
dc.typeArticle

Dosyalar